We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOEV
2776
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$86.3K ﹤0.01%
+152
New +$93.2K
CELL
2777
DELISTED
PhenomeX Inc. Common Stock
CELL
$85.2K ﹤0.01%
+31,797
New +$83.8K
MESO
2778
Mesoblast
MESO
$1.83B
$84.9K ﹤0.01%
+14,587
New +$91.2K
RDNW
2779
RideNow Group
RDNW
$256M
$84.1K ﹤0.01%
13,000
-122,440
-90% -$1.32M
TSAT icon
2780
Telesat
TSAT
$524M
$84K ﹤0.01%
11,200
-22,400
-67% -$174K
PRTK
2781
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$82.2K ﹤0.01%
+43,952
New +$110K
RSKD icon
2782
Riskified
RSKD
$719M
$80.1K ﹤0.01%
+17,336
New +$80.7K
TUYA
2783
Tuya Inc
TUYA
$1.04B
$78.6K ﹤0.01%
41,162
-345,935
-89% -$420K
CONN
2784
DELISTED
Conn's Inc.
CONN
$78K ﹤0.01%
+11,332
New +$89.5K
KGC icon
2785
Kinross Gold
KGC
$27.7B
$77.7K ﹤0.01%
+19,002
New +$75.1K
PHLT
2786
DELISTED
Performant Healthcare Inc
PHLT
$76.9K ﹤0.01%
+21,305
New +$49.9K
REI icon
2787
Ring Energy
REI
$307M
$73.9K ﹤0.01%
30,035
-325,417
-92% -$893K
WE
2788
DELISTED
WeWork Inc.
WE
$72.5K ﹤0.01%
+1,267
New +$119K
LAZR
2789
DELISTED
Luminar Technologies
LAZR
$72.1K ﹤0.01%
+970
New +$106K
TINV.WS
2790
CALL
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$71.7K ﹤0.01%
15,421
-197,442
-93% -$129K
ADP icon
2791
Automatic Data Processing
ADP
$109B
$71.7K ﹤0.01%
300
-53,099
-99% -$13M
SLDP icon
2792
Solid Power
SLDP
$450M
$70.4K ﹤0.01%
+27,700
New +$118K
NNBR icon
2793
NN Inc
NNBR
$237M
$70.1K ﹤0.01%
+46,704
New +$86.5K
XXII
2794
22nd Century Group
XXII
$1.28M
0
SCOR icon
2795
Comscore
SCOR
$113M
$68.7K ﹤0.01%
+2,959
New +$76.7K
ZEPP
2796
Zepp Health
ZEPP
$63.8M
$67.8K ﹤0.01%
11,682
-29,111
-71% -$156K
NOTV
2797
DELISTED
Inotiv
NOTV
$66.7K ﹤0.01%
13,507
-245,224
-95% -$3.05M
EYPT icon
2798
EyePoint Inc
EYPT
$999M
$64.6K ﹤0.01%
+18,471
New +$81.5K
AEVA
2799
Aeva Technologies
AEVA
$956M
$63.1K ﹤0.01%
9,284
+1,822
+24% +$16K
LEV
2800
DELISTED
The Lion Electric Company
LEV
$62.2K ﹤0.01%
27,782
-747,831
-96% -$2.02M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.